Bill
HR 5865
Overview: HR 5865 is the Thalidomide Survivors Compensation Act of 2025, which aims to provide financial assistance to individuals affected by the historical use of the drug thalid
Overview: HR 5865 is the Thalidomide Survivors Compensation Act of 2025, which aims to provide financial assistance to individuals affected by the historical use of the drug thalidomide.
Purpose and Intent: The main goal of this bill is to establish a compensation program for individuals who were born with severe birth defects due to their mothers' use of the drug thalidomide during pregnancy. Thalidomide was a medication widely prescribed in the 1950s and 1960s to treat morning sickness, but it was later found to cause devastating congenital disabilities.
Key Provisions:
- Creates a federal compensation program for thalidomide survivors
- Provides one-time lump-sum payments to eligible individuals based on the severity of their disabilities
- Establishes a process for individuals to apply for and receive compensation
- Authorizes funding for the program and ongoing support services for thalidomide survivors
Affected Parties and Impacts: This bill would directly benefit individuals who were born with thalidomide-related disabilities, providing them with financial assistance to help cover medical expenses and improve their quality of life. It could also have broader societal impacts by acknowledging the historical harms caused by the use of thalidomide and providing support to a vulnerable population.
Procedural and Timeline Considerations: HR 5865 has been introduced in the House of Representatives and is currently in the early stages of the legislative process. The next step would be for the bill to be referred to a relevant committee for further consideration and potential amendments before a vote by the full House.
Compiled from official sources — confirm details with the bill’s official record.
Sign in to ask a question.
